HTP screening for inhibitors of ser/the protein phosphatase 5
HTP screening for inhibitors of ser/the protein phosphatase 5
批准号:
7694097
负责人:
RICHARD E HONKANEN
金额:
$2.5万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-16 至 2011-04-15
关键词:
ApoptosisBackBiologicalBiological AssayBiological ProcessCellsComplexDevelopmentEnvironmentEukaryotic CellFamilyGrowth FactorHormonesHumanLeadMalignant NeoplasmsMeasuresMedicalMetabolismMethodsMolecular BankPP5 protein-serine-threonine phosphatasePharmaceutical PreparationsPhosphoric Monoester HydrolasesPhosphorylationPlayProductionProtein KinaseProtein phosphataseReactionResolutionRoleScreening procedureSerineSignal TransductionSpecificityStimulusStructureThreonineTyrosineWorkcell growthcell typeinhibitor/antagonistmemberphosphatase inhibitorpublic health relevancesenescencesmall moleculetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Almost every cell in the body is constantly exposed to a variety of hormones, growth factors and other agents that influence the biological functions of cells. To integrate and interpret these external stimuli, complex signaling networks have evolved, which allow different types of cells to respond appropriately to their environment. In eukaryotic cells the reversible phosphorylation of proteins regulates many signaling networks that control cell growth, metabolism, differentiation, senescence, and apoptosis. Protein phosphorylation occurs principally on serine, threonine and tyrosine residues, and the phosphorylation reaction is catalyzed by a large family of protein kinases. To date many compounds that function as potent and highly selective inhibitors of "key" protein kinases have been identified, and these inhibitors have proven to be powerful tools to probe the biological and pathological actions of protein kinases. In contrast, much less is known about the biological roles of protein phosphatases. To a large extent this is due to a lack of specific or highly selective small molecule inhibitors. Having developed methods to produce large amounts of catalytically active ser/thr protein phosphatase 5 (PP5), a fluorescent assay to rapidly and reliably measure PP5 activity, and having solved the crystal structure of PP5 at high resolution (1.6 E), we now have the tools in place to develop inhibitors of PP5. The objective of this proposal is to identify a specific or highly selective inhibitor of PP5. There are two specific aims. Aim 1. Conduct a HTP-screen in conjunction with the Molecular Libraries Probe Production Centers Network (MLPCN) to identify compounds that inhibit the catalytic activity of PP5. Aim 2. Back screen compounds identified in Aim 1 against the structurally related phosphatases to determine selectivity, characterize the inhibitors, and work with members of the MLPNC for probe optimization (e.g. increase potency/specificity). The compounds produced from this effort will serve as powerful small molecule probes that will greatly aid the elucidation of the biological and pathological roles played by PP5. They may also serve as lead compounds for the development of new drugs for medical management of human cancer.
PUBLIC HEALTH RELEVANCE: We have identified a protein phosphatase (PP5) that seems to be a key regulator of cell growth. Having developed methods to produce large amounts of PP5 and an assay to measure PP5 activity, we proposal is to identify a specific or highly selective inhibitor of PP5 by conducting a large scale screen in conjunction with the Molecular Libraries Probe Production Centers Network (MLPCN). The compounds produced from this effort will serve as powerful probes that will greatly aid the elucidation of the biological and pathological roles played by PP5.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Methods to enable cholesterol catabolism in human monocyte derived macrophages
-
批准号:8337404
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2011
-
负责人:RICHARD E HONKANEN
-
依托单位:
Methods to enable cholesterol catabolism in human monocyte derived macrophages
-
批准号:8668135
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2011
-
负责人:RICHARD E HONKANEN
-
依托单位:
Methods to enable cholesterol catabolism in human monocyte derived macrophages
-
批准号:8181189
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2011
-
负责人:RICHARD E HONKANEN
-
依托单位:
Methods to enable cholesterol catabolism in human monocyte derived macrophages
-
批准号:8496113
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2011
-
负责人:RICHARD E HONKANEN
-
依托单位:
Development of a HTS-assay for inhibitors of a type 2C protein phosphatase (PPM
-
批准号:7993354
-
项目类别:
-
资助金额:$14.83万
-
财政年份:2010
-
负责人:RICHARD E HONKANEN
-
依托单位:
CARDIOPROTECTIVE AGENTS IN ISCHEMIC MYOCYTES
-
批准号:6183372
-
项目类别:
-
资助金额:$20.6万
-
财政年份:1999
-
负责人:RICHARD E HONKANEN
-
依托单位:
CARDIOPROTECTIVE AGENTS IN ISCHEMIC MYOCYTES
-
批准号:6389765
-
项目类别:
-
资助金额:$21.21万
-
财政年份:1999
-
负责人:RICHARD E HONKANEN
-
依托单位:
CARDIOPROTECTIVE AGENTS IN ISCHEMIC MYOCYTES
-
批准号:6527128
-
项目类别:
-
资助金额:$21.85万
-
财政年份:1999
-
负责人:RICHARD E HONKANEN
-
依托单位:
CARDIOPROTECTIVE AGENTS IN ISCHEMIC MYOCYTES
-
批准号:2752396
-
项目类别:
-
资助金额:$19.36万
-
财政年份:1999
-
负责人:RICHARD E HONKANEN
-
依托单位:
Mechanisms of tumor promotion and carcinogenesis
-
批准号:7030965
-
项目类别:
-
资助金额:$25.66万
-
财政年份:1994
-
负责人:RICHARD E HONKANEN
-
依托单位:
Mechanisms of tumor promotion and carcinogenesis
-
批准号:7027545
-
项目类别:
-
资助金额:$5.1万
-
财政年份:1994
-
负责人:RICHARD E HONKANEN
-
依托单位:
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS
-
批准号:2843978
-
项目类别:
-
资助金额:$24.48万
-
财政年份:1994
-
负责人:RICHARD E HONKANEN
-
依托单位:
Mechanisms of tumor promotion and carcinogenesis
-
批准号:7921141
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1994
-
负责人:RICHARD E HONKANEN
-
依托单位:
Mechanisms of tumor promotion and carcinogenesis
-
批准号:6872168
-
项目类别:
-
资助金额:$26.28万
-
财政年份:1994
-
负责人:RICHARD E HONKANEN
-
依托单位:
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS
-
批准号:2101510
-
项目类别:
-
资助金额:$10.83万
-
财政年份:1994
-
负责人:RICHARD E HONKANEN
-
依托单位:
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS
-
批准号:2101512
-
项目类别:
-
资助金额:$9.86万
-
财政年份:1994
-
负责人:RICHARD E HONKANEN
-
依托单位:
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS
-
批准号:6350138
-
项目类别:
-
资助金额:$23.85万
-
财政年份:1994
-
负责人:RICHARD E HONKANEN
-
依托单位:
Mechanisms of tumor promotion and carcinogenesis
-
批准号:6774616
-
项目类别:
-
资助金额:$26.28万
-
财政年份:1994
-
负责人:RICHARD E HONKANEN
-
依托单位:
Mechanisms of tumor promotion and carcinogenesis
-
批准号:7209837
-
项目类别:
-
资助金额:$24.92万
-
财政年份:1994
-
负责人:RICHARD E HONKANEN
-
依托单位:
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS
-
批准号:2101511
-
项目类别:
-
资助金额:$8.75万
-
财政年份:1994
-
负责人:RICHARD E HONKANEN
-
依托单位:
国内基金
海外基金
患者依从性与脑卒中后跌倒风险相关性及“Teach-Back ”护理干预效应研究
-
批准号:2026JJ81464
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:叶婷
-
依托单位:
基于Teach-back药学科普模式的慢阻肺患者吸入用药依从性及疗效研究
-
批准号:2024KP61
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:余丹
-
依托单位:
基于Quench-Back保护的超导螺线管磁体失超过程数值模拟研究
-
批准号:51307073
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2013
-
负责人:郭兴龙
-
依托单位: